Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endometrial thickness is the measurement (in mm) of the uterine lining by ultrasound, reflecting the proliferation and shedding of endometrial tissue in response to hormonal changes. Normal values vary by menstrual cycle phase in premenopausal women and are generally less than 4-5 mm in postmenopausal women. Elevated thickness may indicate hormonal imbalances, endometrial hyperplasia, or malignancy and is a key parameter in gynecological assessment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endometrial thickness (ET).